{
  "ticker": "PTGX",
  "company_name": "Protagonist Therapeutics, Inc.",
  "success": true,
  "trials": [
    {
      "nct_id": "NCT07153146",
      "title": "Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of PN-881 in Healthy Subjects.",
      "status": "RECRUITING",
      "phase": "PHASE1",
      "condition": "Healthy Volunteer",
      "start_date": "2025-10-07",
      "completion_date": "2026-06-15",
      "enrollment": 0,
      "sponsor": "Protagonist Therapeutics, Inc."
    },
    {
      "nct_id": "NCT04202965",
      "title": "PTG-300 in Subjects With Hereditary Hemochromatosis",
      "status": "COMPLETED",
      "phase": "PHASE2",
      "condition": "Hereditary Hemochromatosis",
      "start_date": "2020-03-19",
      "completion_date": "2022-02-15",
      "enrollment": 0,
      "sponsor": "Protagonist Therapeutics, Inc."
    },
    {
      "nct_id": "NCT04819620",
      "title": "Pharmacokinetics of PN-232 in Healthy Volunteers",
      "status": "COMPLETED",
      "phase": "PHASE1",
      "condition": "Healthy Subjects",
      "start_date": "2021-05-13",
      "completion_date": "2022-06-16",
      "enrollment": 0,
      "sponsor": "Protagonist Therapeutics, Inc."
    },
    {
      "nct_id": "NCT04516382",
      "title": "Pharmacokinetics and Pharmacodynamics of Different PTG-300 Regimens in Healthy Volunteers",
      "status": "COMPLETED",
      "phase": "PHASE1",
      "condition": "Healthy Volunteers",
      "start_date": "2020-09-14",
      "completion_date": "2021-06-30",
      "enrollment": 0,
      "sponsor": "Protagonist Therapeutics, Inc."
    },
    {
      "nct_id": "NCT04504383",
      "title": "PN-943 in Adults With Moderate to Severe Active Ulcerative Colitis (UC)",
      "status": "COMPLETED",
      "phase": "PHASE2",
      "condition": "Ulcerative Colitis Chronic Moderate, Ulcerative Colitis Chronic Severe",
      "start_date": "2020-08-05",
      "completion_date": "2023-02-16",
      "enrollment": 0,
      "sponsor": "Protagonist Therapeutics, Inc."
    },
    {
      "nct_id": "NCT02895100",
      "title": "Safety and Efficacy Study of PTG-100 in the Treatment of Moderate to Severe Ulcerative Colitis",
      "status": "TERMINATED",
      "phase": "PHASE2",
      "condition": "Ulcerative Colitis",
      "start_date": "2016-12",
      "completion_date": "2018-03-26",
      "enrollment": 0,
      "sponsor": "Protagonist Therapeutics, Inc."
    },
    {
      "nct_id": "NCT06033586",
      "title": "Study to Evaluate the Long-term Safety of Rusfertide (PTG-300) in Subjects With Polycythemia Vera",
      "status": "ACTIVE_NOT_RECRUITING",
      "phase": "PHASE3",
      "condition": "Polycythemia Vera",
      "start_date": "2024-01-22",
      "completion_date": "2027-04-01",
      "enrollment": 0,
      "sponsor": "Protagonist Therapeutics, Inc."
    },
    {
      "nct_id": "NCT04054921",
      "title": "Safety Study for Beta Thalassemia Subjects on PTG-300",
      "status": "COMPLETED",
      "phase": "PHASE2",
      "condition": "\u03b2-thalassemia, Ineffective Erythropoiesis",
      "start_date": "2019-05-10",
      "completion_date": "2020-07-31",
      "enrollment": 0,
      "sponsor": "Protagonist Therapeutics, Inc."
    },
    {
      "nct_id": "NCT04057040",
      "title": "Hepcidin Mimetic in Patients With Polycythemia Vera (REVIVE)",
      "status": "COMPLETED",
      "phase": "PHASE2",
      "condition": "Polycythemia Vera",
      "start_date": "2019-10-01",
      "completion_date": "2024-06-17",
      "enrollment": 0,
      "sponsor": "Protagonist Therapeutics, Inc."
    },
    {
      "nct_id": "NCT03802201",
      "title": "Study of PTG-300 in Non-Transfusion Dependent and Transfusion-Dependent Beta-Thalassemia Subjects With Chronic Anemia",
      "status": "COMPLETED",
      "phase": "PHASE2",
      "condition": "\u03b2-thalassemia, Ineffective Erythropoiesis, Chronic Anemia",
      "start_date": "2018-12-19",
      "completion_date": "2020-07-31",
      "enrollment": 0,
      "sponsor": "Protagonist Therapeutics, Inc."
    }
  ],
  "summary": {
    "total_trials": 14,
    "by_phase": {
      "PHASE1": 5,
      "PHASE2": 7,
      "PHASE3": 2
    },
    "by_status": {
      "RECRUITING": 1,
      "COMPLETED": 10,
      "TERMINATED": 1,
      "ACTIVE_NOT_RECRUITING": 2
    },
    "active_trials": 3,
    "completed_trials": 10,
    "conditions": [
      "Celiac Disease",
      "Healthy Subjects",
      "Healthy Volunteer",
      "Healthy Volunteers",
      "Hereditary Hemochromatosis",
      "Polycythemia Vera",
      "Ulcerative Colitis",
      "Ulcerative Colitis Chronic Moderate, Ulcerative Colitis Chronic Severe",
      "\u03b2-thalassemia, Ineffective Erythropoiesis",
      "\u03b2-thalassemia, Ineffective Erythropoiesis, Chronic Anemia"
    ],
    "lead_stage": "phase_3"
  },
  "provenance": {
    "source": "ClinicalTrials.gov API v2",
    "timestamp": "2026-01-29T12:21:08.453775",
    "search_query": "Protagonist Therapeutics, Inc.",
    "url": "https://clinicaltrials.gov/search?term=Protagonist+Therapeutics,+Inc."
  }
}